85 related articles for article (PubMed ID: 7541220)
1. Expression of immunoreactive and bioactive activin A protein in adult murine lung after bleomycin treatment.
Matsuse T; Fukuchi Y; Eto Y; Matsui H; Hosoi T; Oka T; Ohga E; Nagase T; Orimo H
Am J Respir Cell Mol Biol; 1995 Jul; 13(1):17-24. PubMed ID: 7541220
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin.
Aoki F; Kurabayashi M; Hasegawa Y; Kojima I
Am J Respir Crit Care Med; 2005 Sep; 172(6):713-20. PubMed ID: 15976370
[TBL] [Abstract][Full Text] [Related]
3. Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis.
Matsuse T; Ikegami A; Ohga E; Hosoi T; Oka T; Kida K; Fukayama M; Inoue S; Nagase T; Ouchi Y; Fukuchi Y
Am J Pathol; 1996 Mar; 148(3):707-13. PubMed ID: 8774126
[TBL] [Abstract][Full Text] [Related]
4. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.
Higashiyama H; Yoshimoto D; Kaise T; Matsubara S; Fujiwara M; Kikkawa H; Asano S; Kinoshita M
Exp Mol Pathol; 2007 Aug; 83(1):39-46. PubMed ID: 17274978
[TBL] [Abstract][Full Text] [Related]
7. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
Shen Y; Zhao HL; Du J; Li YT; Tan F; Huang CG; Pei G
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1071-7. PubMed ID: 16445573
[TBL] [Abstract][Full Text] [Related]
8. Alterations in DNA synthesis and cellular constituents in mouse lung following bleomycin injections.
Katsura H; Taguchi T; Kida K
Am J Respir Cell Mol Biol; 1992 Feb; 6(2):190-6. PubMed ID: 1371689
[TBL] [Abstract][Full Text] [Related]
9. Regulation of alveolar macrophage transforming growth factor-beta secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat.
Khalil N; Whitman C; Zuo L; Danielpour D; Greenberg A
J Clin Invest; 1993 Oct; 92(4):1812-8. PubMed ID: 7691887
[TBL] [Abstract][Full Text] [Related]
10. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis.
Harrison JH; Lazo JS
J Pharmacol Exp Ther; 1988 Dec; 247(3):1052-8. PubMed ID: 2462625
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study.
Khalil N; O'Connor RN; Flanders KC; Unruh H
Am J Respir Cell Mol Biol; 1996 Feb; 14(2):131-8. PubMed ID: 8630262
[TBL] [Abstract][Full Text] [Related]
12. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
[TBL] [Abstract][Full Text] [Related]
13. Lung cytokine production in bleomycin-induced pulmonary fibrosis.
Phan SH; Kunkel SL
Exp Lung Res; 1992; 18(1):29-43. PubMed ID: 1374023
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice.
Xiao JH; Zhang JH; Chen HL; Feng XL; Wang JL
Planta Med; 2005 Mar; 71(3):225-30. PubMed ID: 15770542
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats.
Madtes DK; Busby HK; Strandjord TP; Clark JG
Am J Respir Cell Mol Biol; 1994 Nov; 11(5):540-51. PubMed ID: 7524566
[TBL] [Abstract][Full Text] [Related]
16. [The effect of erythromycin on NF-kappa B activation and cytokines mRNA expression in bleomycin-induced pulmonary fibrosis in rats].
Li Y; He B; Wang H
Zhonghua Jie He He Hu Xi Za Zhi; 1999 Dec; 22(12):725-7. PubMed ID: 11776779
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor-beta type I and type II receptors is altered in rat lungs undergoing bleomycin-induced pulmonary fibrosis.
Zhao Y; Shah DU
Exp Mol Pathol; 2000 Oct; 69(2):67-78. PubMed ID: 11001857
[TBL] [Abstract][Full Text] [Related]
18. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice.
Harrison JH; Hoyt DG; Lazo JS
Mol Pharmacol; 1989 Aug; 36(2):231-8. PubMed ID: 2475758
[TBL] [Abstract][Full Text] [Related]
19. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway.
Meng J; Zou Y; Hu C; Zhu Y; Peng Z; Hu G; Wang Z; Tao L
Shock; 2012 Nov; 38(5):567-73. PubMed ID: 23042199
[TBL] [Abstract][Full Text] [Related]
20. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis.
Takahashi F; Takahashi K; Okazaki T; Maeda K; Ienaga H; Maeda M; Kon S; Uede T; Fukuchi Y
Am J Respir Cell Mol Biol; 2001 Mar; 24(3):264-71. PubMed ID: 11245625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
